Form 4: BIO-key International Executive Acquires Shares

BIO-key International's Chief Technology Officer, Mira LaCous, acquired shares through an employee stock purchase plan.

Summary

• Mira LaCous, Chief Technology Officer at BIO-key International, acquired 250 shares of common stock.
• The acquisition occurred on June 30, 2026, under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan.
• The purchase price was $3.83 per share.
• Following the transaction, LaCous beneficially owns 4,076 shares.
• All share amounts reflect a 1-for-10 reverse stock split effective April 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction through an employee stock purchase plan rather than a strategic company announcement.

Positives

• Executive participation in employee stock purchase plans can indicate confidence in the company's future.
• Acquisition of shares by a key executive.

Future Outlook

No specific future outlook or guidance is provided in this filing, which is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions and do not typically provide strategic insights. The acquisition by a CTO through an employee stock purchase plan is a common event for executives seeking to increase their stake in the company.

Stakeholder Impact

• Shareholders: The acquisition by an executive may be viewed positively as a sign of confidence, but the impact on share price is likely minimal given the nature of the transaction.

Key Dates

Keywords

BIO-key International, BKYI, Form 4, Insider Trading, Stock Purchase Plan, Executive Compensation, Securities Exchange Act